$TLRY When the price ran up to $22 in early October, most investors likely held on instead of selling, expecting cannabis rescheduling. Then, over the next month, fears around the AI sector and the broader market dragged it down into the $12 range, and after the reverse split it fell to the low $7s. Just when it felt like everyone had given up, the cannabis rescheduling news finally came out, pushing it back up to $12 and briefly as high as $15. However, there was no mention of full legalization or banking reform, which led to disappointment and a pullback over the next two days. This wasn’t really a “sell the news” event, but rather a sell-off driven by unmet expectations. Still, looking toward 2026, it’s hard to deny that this company has more upside potential than most, and that’s what I’m betting on.